AWARDPURCHASE ORDERSmall business
Purchase order 75N95022P00519TRILINK BIOTECHNOLOGIES, LLC
Overview
Award facts
- Net obligations
- $29.64K
- $29,642of $29.64K potential value
- Outlays (paid to date)
- $29.64K
- $29.64K paid of $29.64K obligated$29,642
- Period of performance
- Aug 19, 2022 to Oct 18, 2022
- Ended
- Modifications
- 1
- Latest action May 12, 2026
- Contract type
- Purchase order
- PIID 75N95022P00519
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
MODIFIED HUMAN MRNA TRANSCRIPTS
Dates and value
- Award date
- Signed on Aug 19, 2022
- Current value
- $29,642Base and exercised options
- Potential value (if all options are exercised)
- $29,642
Obligations by fiscal year of action
- FY2026: -$5 (de-obligation)
- FY2022: $29,647
Total across 2 fiscal years: $29,642
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded May 12, 2026. View on USAspending · Recipient on SAM.gov
Recipient
LocationSAN DIEGO, CA
UEIJTZNJ1K5HUA4
CAGE code3Y9Z9
Business sizeSmall businessSize at award, per the contracting officer
Organization typePartnership
Parent companyTRILINK BIOTECHNOLOGIES, LLC
Business types and certifications
For-profit organizationLimited liability companyPartnership or LLP
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIDA
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIDA
- Funded from
- National institute on aging (0843)Program activities075-0843Federal accounts (agency financial reports)
Place of performance
- Place of performance
- San Diego, California 92121-5801
- Congressional district (place of performance)
- CA-51As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- 6505DRUGS AND BIOLOGICALS (product)
Competition
- Extent competed
- Not competed under SAPG
- Reason not competed
- SAP non-competition (FAR 13)SP2
- Solicitation procedures
- Simplified acquisitionSP1
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- 75N95022Q00352
- Solicitation date
- Jul 15, 2022
- Notices
- Award Notice posted Aug 19, 2022
- Combined Synopsis/Solicitation posted Jul 15, 2022
- Sources Sought posted Jun 29, 2022
Contract details
- Subcontracting plan
- Plan not requiredB
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Aug 19, 2022Base obligation at award: $29,647
- Latest action
- May 12, 2026 — Funding onlyModification P00001; obligation change -$5; funding only: changes obligations, not scope
- Latest funding action
- May 12, 2026 — Funding onlyModification P00001; obligation change -$5; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Funding only1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$5
- Latest action: change in base and all options
- -$5
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Mfg in U.S.D
Structure
- Award or IDV
- Award
- Award type
- Purchase orderB
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N950
- Transactions recorded under this award key
- 2
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N950
- Treasury accounts
- 075-2022/2022-0843-000
- Object classes
- 25.6: Medical care
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression